LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.4100
+0.0150 (3.80%)
At close: Apr 10, 2026
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 49.7 million as of April 10, 2026. Its market cap has increased by 30.36% in one year.
Market Cap
49.70M
Enterprise Value
71.30M
Revenue
26.80M
Ranking
n/a
PE Ratio
18.07
Stock Price
0.41
Market Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 49.70M, a decrease of -19.41%. That is a compound annual growth rate of -6.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 49.70M | 17.14% |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Decibel Cannabis Company | 75.02M |
| BioNxt Solutions | 68.66M |
| Vext Science | 65.27M |
| Planet 13 Holdings | 64.01M |
| Leef Brands | 55.88M |
| ZYUS Life Sciences | 45.90M |
| C21 Investments | 43.04M |
| iAnthus Capital Holdings | 34.86M |